Prolonged sars-cov-2 infection and organizing pneumonia in a patient with follicular lymphoma, treated with obinutuzumab—challenging recognition and treatment

HIGHLIGHTS

• who: E. u0141yu017cwa et al. from the 1, Warsaw, Poland have published the research: Prolonged SARS-CoV-2 Infection and Organizing Pneumonia in a Patient with Follicular Lymphoma, Treated with Obinutuzumabu2014Challenging Recognition and Treatment, in the Journal: Viruses 2023, 15, x FOR PEER REVIEW of /2023/
• what: There are only a few case reports of prolonged SARS-CoV-2 infections in patients with haematological disorders after anti-CD20 treatment.

SUMMARY

Rituximab and obinutuzumab are monoclonal_antibodies against CD20 and are used in the therapy of chronic lymphocytic leukaemia and follicular lymphoma, among . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.